Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GSK3A | P49840 | 1/20 | 0.50 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ABL1 | P00519 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | QPCT | Q16769 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14761839 | 0.85 | GSK3A (0.46) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| SCHEMBL14233263 | 0.81 | — | — | |
| SCHEMBL839846 | 0.77 | TSHR (0.50) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| SCHEMBL853544 | 0.77 | TSHR (0.50) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| SCHEMBL10979078 | 0.77 | TSHR (0.50) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| SCHEMBL1969772 | 0.77 | TSHR (0.55) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| SCHEMBL10963438 | 0.77 | TSHR (0.50) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| Hydrochloric Acid SCHEMBL2980753 | 0.76 | TSHR (0.48) | TSHRGSK3AGSK3BALDH1A1KMT2A | |
| SCHEMBL7453981 | 0.74 | TSHR (0.47) | TSHRGSK3AGSK3BKMT2AMEN1 | |
| SCHEMBL9755587 | 0.74 | TSHR (0.47) | TSHRGSK3AGSK3BALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6489341-B1 | REDUCING OR AVOIDING ADVERSE EFFECTS ASSOCIATED WITH THE ADMINISTRATION OF SERTINDOLE, BY ADMINISTRATING A SERTINDOLE DERIVATIVE SUCH AS NOR-SERTINDOLE, 5-OXO-SERTINDOLE, DEHYDRO-SERTINDOLE OR DEHYDRO-NOR-SERTINDOLE | SEPRACOR INC. | 2002-12-03 | — | — | US | disclosed |
| EP-0726898-B1 | PHENYLINDOLE COMPOUNDS | LUNDBECK & CO AS H (DK) | 2000-12-20 | — | — | EP | disclosed |
| WO-2000072837-A2 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROLEPTIC AND RELATED DISORDERS USING SERTINDOLE DERIVATIVES | SEPRACOR INC. (US) | 2000-12-07 | — | — | WO | disclosed |
| US-5703087-A | PSYCHOLOGICAL DISORDERS | H. LUNDBECK A/S (DK) | 1997-12-30 | — | — | US | disclosed |
| EP-0726898-A1 | PHENYLINDOLE COMPOUNDS | H. LUNDBECK A/S (DK) | 1996-08-21 | — | — | EP | disclosed |
| WO-1995012591-A1 | PHENYLINDOLE COMPOUNDS | H. LUNDBECK A/S (DK) | 1995-05-11 | — | — | WO | disclosed |
| US-5075301-A | FURAN DERIVATIVES USEFUL FOR THE TREATMENT OF GASTRO-INTESTINAL DISORDERS | KYOWA HAKKO KOGYO, CO., LTD. (JP) | 1991-12-24 | — | — | US | disclosed |
| EP-0413343-A2 | Furan derivatives | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1991-02-20 | — | — | EP | disclosed |
| US-4105774-A | CNS ANTITUMOR, INTRAPERITONEAL LEUKEMIA, MELANOMA, LEWIS LUNG CARCINOMA | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF STATE (US) | 1978-08-08 | — | — | US | disclosed |